Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ISSN Print: 2278-1668, Online: 2278-0513

About Us

Clinical Cancer Investigation Journal [ISSN:2278-0513], a publication of Middle-Eastern Association for Cancer Research (MEACR), is a double-blind peer-reviewed online journal with quarterly print on demand compilation of issues published. The journal's full text is available online at http://www.ccij-online.org. The journal allows free access (Open Access).

Publishing frequency: Bimonthly/6 issues per year

Indexing Information
Embase, Index Copernicus, EBSCO Publishing's Electronic Databases, CAS Source Index, ABCD Journal Indexing, Asian Science Citation Index (ASCI).

 

Aim and Scope

The Clinical Cancer Investigation Journal is a double-blind peer-reviewed publication dedicated to advancing the understanding and treatment of cancer through rigorous clinical research. Our journal provides a platform for the dissemination of high-quality, innovative studies spanning various aspects of cancer diagnosis, prognosis, therapy, and survivorship. We welcome the knowledge base of cancer biology, pathology, genetics, immunology, and therapeutic interventions. With a commitment to excellence and relevance in the field of oncology, our mission is to foster collaboration among researchers and clinicians worldwide, ultimately striving towards improved outcomes for cancer patients.

 

Announcement and Advertisement
Announcements regarding scientific activities such as conferences, symposium, are published for free. Advertisements can be either published or placed on website as banners.

 

Copyright © 2024 Clinical Cancer Investigation Journal, All rights are reserved and for all open access contents, the Creative Commons licensing terms apply.
Online since 01 December, 2011
Creative Commons License 
ISSN Print: 2278-1668, Online: 2278-0513